Health Catalyst (HCAT) affiliate files to sell 18,804 restricted shares on 06/01/2026

Rhea-AI Filing Summary

Health Catalyst, Inc. reports a proposed sale of 18,804 shares of Common Stock under Form 144. The filing lists these as restricted stock associated with compensation, with the proposed sale date of 06/01/2026.

The excerpt also shows 26,970 shares sold in the prior three months and indicates 73,894,020 shares outstanding as of 06/01/2026.

Insights

Securities Compliance Analyst

Form 144 notifies the market of a planned sale of restricted shares by an insider/affiliate.

The filing lists 18,804 shares of restricted Common Stock proposed for sale on 06/01/2026; the method is labeled compensation. This is a regulatory notice required before certain sales by affiliates.

Timing and proceeds treatment are not specified in the excerpt. Subsequent Form 4 or a resale report would show actual sale completion and net proceeds.

Equity Markets Analyst

The proposed sale size is small relative to shares outstanding.

The filing shows 18,804 shares proposed versus 73,894,020 shares outstanding as of 06/01/2026, indicating limited potential overhang from this single notice.

Past three‑month disposals of 26,970 shares are shown; watch for any Form 4s that confirm execution or method of sale.

Key Figures

Proposed sale: 18,804 shares Recent disposals (past 3 months): 26,970 shares Shares outstanding: 73,894,020 shares

3 metrics

Proposed sale 18,804 shares Proposed sale date <date>06/01/2026</date>

Recent disposals (past 3 months) 26,970 shares Securities sold during the past three months (listed in the excerpt)

Shares outstanding 73,894,020 shares Outstanding as of <date>06/01/2026</date>

Key Terms

Restricted Stock, Form 144, Compensation

3 terms

Restricted Stock financial

"Securities To Be Sold | Restricted Stock | Health Catalyst, Inc."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"CONTENT METADATA: "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Compensation financial

"Securities To Be Sold ... | 06/01/2026 | Compensation"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	18804	25765.24	73894020	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Restricted Stock	Health Catalyst, Inc.			18804	06/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jason Alger c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	03/02/2026	26970	44767.5

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Health Catalyst's (HCAT) Form 144 report show?

It shows a proposed sale of 18,804 restricted shares with a sale date of 06/01/2026. The filing labels the shares as linked to compensation and is a pre‑sale regulatory notice by an affiliate.

How large is the proposed sale versus HCAT shares outstanding?

The proposed sale is 18,804 shares; outstanding shares are listed as 73,894,020 as of 06/01/2026. This single notice represents a small fraction of the outstanding share count.

Were there recent related dispositions by insiders in the past three months?

Yes; the excerpt lists 26,970 shares sold during the past three months by an identified holder. That figure appears separately from the proposed 18,804‑share sale.

Does the Form 144 indicate how the shares will be sold or proceeds used?

No method or use of proceeds is specified in the excerpt. The filing classifies the securities as restricted stock tied to compensation, but sale mechanics are not detailed here.

When does a Form 144 become relevant to market activity for HCAT?

A Form 144 signals an affiliate's intent to sell restricted securities; it becomes relevant if a subsequent report (e.g., Form 4) confirms execution or details sale method and timing.